Abstract
The preparation of a series of novel acyclic and macrocyclic Schiff-base ligands, designed to model the tyrosinase receptor, is described.
ACKNOWLEDGMENTS
The authors thank MINTEK for a bursary (to K.W.W.), and MINTEK, Rhodes University and the National Research Foundation for generous financial support.